Investment

The Reason behind Longevity: start-up opportunities

We connected with Reason (the person) to get the inside track on hot areas for Longevity R&D.   Longevity.Technology: Advocacy runs through Reason like a...

The Longevity landscape and investment potential

Hype or hyper-exciting? Kate Batz of Longevity.Capital shares her views on the Longevity landscape and its investment potential: pragmatic optimism, but full of opportunity. In the...

Cerevance raising $60m for brain disease drug discovery

Company awaits Phase 2 trial readout for new Parkinson’s drug as part of its mission to combat brain disease. In the world of Longevity start-ups,...

Longevity venture capital – a case in point

Talking venture capital and the Longevity investment landscape with Elysium Health CEO Eric Marcotulli. While we believe it's clear the investment opportunity in Longevity is...

VR for brain training and tracking cognitive health

Virtuleap currently fundraising to build headcount and capitalise on cognitive illness detection algorithms. Ever since the US Federal Trade Commission fined Lumosity $2 million for...

Start-ups – are you solving a meaningful problem?

Forward Partners’ Luke Smith shares his views on early stage investment. With the inaugural Biohacking Congress arriving in London tomorrow, we had just enough time...

Biohacking and the future of health and Longevity

Talking investment with Octopus Ventures’ Uzma Choudry and what she's looking for in a breakthrough technology. Next week, the first Biohacking Congress will be held...

New Longevity event to debut in Croatia

Aging2.0 announces inaugural VOLTAGE event, connecting entrepreneurs and innovators to build a single market for active and healthy aging in Europe. This April, Aging2.0 will...

Functional age biomarker tracking goes digital

AgeMeter brings physical age measurement into the 21st century. With the recent explosion in direct-to-consumer genetic testing kits and services, the measurement of our functional...

NeuroTech Analytics releases industry-first report

New open-access analytical report profiles top technologies, sectors, trends, companies, investors, R&D hubs and influencers in the Global NeuroTech Industry “Global NeuroTech Industry Landscape Overview...

Proteomics and biological age measurement

AgeCurve closes in on first round investment as it builds its team with the support of key opinion leaders in aging research. UK start-up AgeCurve...

Alkahest Parkinson’s clinical trial gets funding boost

Alkahest announced today that they have initiated a phase 2 clinical trial with funding from the Michael J. Fox Foundation (MJFF). Today's press release reveals...

Insurer puts down £20m to research an aging rethink

A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society. The world is...

Singapore agetech – ones to watch in 2020

Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...

Singapore to start human Longevity studies

Prof Brian Kennedy: "One of the reasons I came to Singapore is that the government recognises the problem of aging." In this second part of...

Revel Pharmaceuticals’ seed round for anti-aging drugs

Top Yale lab spawns new company focused on development of glucosepane-cleaving drugs. San Francisco based biotech start-up Revel Pharmaceuticals has announced itself to the...

Evolution 2.0 prize: The $10 million question

Major new prize announced to help identify how cells intentionally self-organise and communicate; George Church part of judging panel. The origin of life is often...

Longevity stocks: Stay private longer?

Going public as a Longevity stock is all about good timing and good clinical results: Some stand-out performers have experienced a volatile year. The world’s...

NeoGenomics acquires Human Longevity’s oncology tech

Acquisition of Human Longevity’s oncology division for $37m demonstrates both the opportunities and challenges for Longevity investing. On Friday, NeoGenomics announced that it had agreed...

CES 2020: AgeTech pillow talk and wearables

AgeTech is providing some of the most interesting devices in the Longevity world and CES 2020 is the place to show off the inventions...

Latest articles

Longevity 2020: shaping-up nicely

Over 45 confirmed speakers for this 5-day online event and a big thank you for your interest. We're moving fast! Longevity 2020 started just over...

Telomeres on repeat to inhibit inflamm-aging

Coming around again – Italian team hopes to use repeated nucleobases to delay aging through extending telomeres. Inflammation is a double-edged sword; while it is necessary...

Join me at my 100th birthday party in 2049!

We speak with GRG's Johnny Adams, a key contributor to the Longevity2020 online conference, about his quest for more healthy years. One of the speakers at this month’s...

Call for consensus in defining biological aging

We speak with a key contributor to the Longevity2020 online conference about biological aging. UK start-up AgeCurve is focused on the measurement of aging and...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.